🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a single-center, single-arm, open-label clinical study, to explore ...
Status
Unknown
Location
Fudan University Shanghai Cancer Center
Start Date
2022-07-12
Trial ID
NCT05435313
Treatments Being Tested
The expanded access program allows people to gain access to an unlicensed t...
Status
No Longer Available
Location
Multiple Locations
Start Date
TBD
Trial ID
NCT06195514
Treatments Being Tested
Colorectal cancer (CRC) is the fourth leading cause of cancer death worldwi...
Status
Active Not Recruiting
Location
Tianjin Cancer Hospital
Start Date
2023-07-01
Trial ID
NCT07491159
This is a Phase 1b/2, open-label, dose escalation, dose expansion and dose ...
Status
Recruiting
Location
Honor Health Research Institute
Start Date
2022-06-15
Trial ID
NCT05405595
This study is designed to evaluate the safety, tolerability, and efficacy o...
Status
Not Yet Recruiting
Location
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Start Date
2026-01-21
Trial ID
NCT07353268
This is an open-label, multicenter Phase 3 study to evaluate the safety and...
Status
Recruiting
Location
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Start Date
2026-07-31
Trial ID
NCT07722494
Treatments Being Tested
This is a phase Ib/II clinical study. All participants are patients with ad...
Status
Not Yet Recruiting
Location
Peking University Cancer Hospital
Start Date
2026-07-15
Trial ID
NCT07621159
Treatments Being Tested
The efficacy of combining TKI with PD-1 inhibitor in the treatment of advan...
Status
Recruiting
Location
National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College
Start Date
2023-12-01
Trial ID
NCT06543836
Treatments Being Tested
This is a multicenter, randomized, controlled, phase II study to evaluate t...
Status
Unknown
Location
Shanghai Zhongshan Hospital
Start Date
2022-07-13
Trial ID
NCT05278351
Treatments Being Tested
Efficacy Study of Digoxin Combined with Serplulimab and Chemotherapy in Fir...
Status
Not Yet Recruiting
Location
Anyang Cancer Hospital
Start Date
2025-08-01
Trial ID
NCT07025850
Treatments Being Tested